Why is Indo US Bio-Tech falling/rising?

As of 17-Nov, Indo US Bio-Tech Ltd is experiencing a decline in its stock price, currently at Rs 123.90, which represents a decrease of 5.0 or 3.88%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total drop of 7.61% during this period. It is also trading close to its 52-week low, just 4.12% above Rs 118.8. The stock's performance over the past week shows a decline of 4.62%, while it has underperformed its sector by 5.17%. Despite some positive indicators such as high management efficiency and strong debt servicing ability, the stock's recent movement reflects a lack of investor participation, with delivery volume significantly lower than average.
Broader market context indicates that while Indo US Bio-Tech has seen a year-to-date decline of 60.67%, the benchmark Sensex has gained 8.72% in the same period. This stark contrast highlights the stock's struggles relative to the broader market. In the short term, the stock's performance over the past week is notably worse than the Sensex's gain of 1.69%, further emphasizing its current challenges. Although the company has reported positive financial results and growth in profits, the overall market sentiment and recent trading patterns suggest that investors are cautious, contributing to the stock's downward trajectory.